Market Cap 5.34M
Revenue (ttm) 1.73M
Net Income (ttm) -23.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,350.29%
Debt to Equity Ratio -0.31
Volume 31,170,545
Avg Vol 600,242
Day's Range N/A - N/A
Shares Out 13.65M
Stochastic %K 5%
Beta 1.16
Analysts Strong Sell
Price Target $14.94

Company Profile

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response a...

Industry: Medical Devices
Sector: Healthcare
Phone: 512 774 8930
Address:
1489 West Warm Springs Road, Suite 110, Henderson, United States
MoneyMacG
MoneyMacG Aug. 26 at 8:49 PM
0 · Reply
MoneyMacG
MoneyMacG Aug. 26 at 8:41 PM
0 · Reply
FormulaOneTrader
FormulaOneTrader Aug. 26 at 8:34 PM
0 · Reply
brwcy81
brwcy81 Aug. 26 at 6:38 PM
$VNRX An 8-K filed August 24 reported an additional 553,097 shares issued on August 20, 2026 to Lind Global Asset Management to satisfy a $250,000 convertible-note conversion. That brings the total to roughly 14.20 million.
0 · Reply
SerendipiTea
SerendipiTea Aug. 26 at 5:31 PM
$VNRX 29M shares traded. They must be dumping a massive amount of new shares on the market today via the ATM, timed to correlate with the sepsis PR knowing there would be a lot of liquidity from day traders.
1 · Reply
BinaryLogic
BinaryLogic Aug. 26 at 4:26 PM
$VNRX Debt conversion(s) to Lind in common stock, and then Lind liquidates those shares onto the market. The cycle will repeat until the liquidity issues that I have highlighted previously are resolved. Again-a licensing agreement with up front capital, milestone payments and ongoing double-digit royalties completely changes the valuation here (IMO) and should send the SP several hundred % higher from present levels. The key here is timing and execution, because the Lind dynamic will continue ongoing endlessly in the interim. $0.15-0.30 as I have consistently stated, and the SP is approaching that range now. A placement should have been done to this point - the endless ATM is equally damaging. https://www.sec.gov/Archives/edgar/data/93314/000147793226005251/0001477932-26-005251-index.html
1 · Reply
santihago
santihago Aug. 26 at 4:11 PM
$VNRX What a crime..
1 · Reply
Stanman13
Stanman13 Aug. 26 at 4:00 PM
$VNRX $12 a year ago... With time all things change.. 📈 great price to plant some seeds see if they sprout 🌱
0 · Reply
NGupup
NGupup Aug. 26 at 4:00 PM
$VNRX ☝️Now it's good ⬆️⬆️🔥
0 · Reply
brwcy81
brwcy81 Aug. 26 at 3:17 PM
$VNRX maybe bounce ah
0 · Reply
Latest News on VNRX
VolitionRx announces publication on Nu.Q NETs H3.1 biomarker

2026-08-26T12:26:48.000Z - 8 hours ago

VolitionRx announces publication on Nu.Q NETs H3.1 biomarker


VolitionRx reports Q2 revenue $400K, consensus $474.34K

2026-08-16T14:09:56.000Z - 10 days ago

VolitionRx reports Q2 revenue $400K, consensus $474.34K


VolitionRx Earnings Call Transcript: Q2 2026

Aug 14, 2026, 8:30 AM EDT - 12 days ago

VolitionRx Earnings Call Transcript: Q2 2026


VolitionRx Earnings release: Q2 2026

Aug 14, 2026, 8:30 AM EDT - 12 days ago

VolitionRx Earnings release: Q2 2026


VolitionRx Quarterly report: Q2 2026

Aug 14, 2026, 8:30 AM EDT - 12 days ago

VolitionRx Quarterly report: Q2 2026


VolitionRx Slides: Corporate presentation

Aug 1, 2026, 8:00 AM EDT - 25 days ago

VolitionRx Slides: Corporate presentation


VolitionRx Slides: Corporate presentation

Jul 21, 2026, 7:00 AM EDT - 5 weeks ago

VolitionRx Slides: Corporate presentation


VolitionRx Registration statement: Registration filing

Jul 10, 2026, 8:00 AM EDT - 6 weeks ago

VolitionRx Registration statement: Registration filing


VolitionRx resumed with a Buy at Maxim

2026-06-18T12:46:44.000Z - 2 months ago

VolitionRx resumed with a Buy at Maxim


VolitionRx announces collaboration with Sysmex

2026-06-17T12:21:03.000Z - 2 months ago

VolitionRx announces collaboration with Sysmex


VolitionRx Announces Collaboration with Sysmex

Jun 17, 2026, 8:15 AM EDT - 2 months ago

VolitionRx Announces Collaboration with Sysmex


VolitionRx Announces Pricing of $4.6 Million Public Offering

Jun 7, 2026, 6:30 PM EDT - 2 months ago

VolitionRx Announces Pricing of $4.6 Million Public Offering


VolitionRx Proxy statement: Proxy filing

Jun 2, 2026, 8:00 AM EDT - 3 months ago

VolitionRx Proxy statement: Proxy filing


VolitionRx Earnings Call Transcript: Q1 2026

May 15, 2026, 8:30 AM EDT - 3 months ago

VolitionRx Earnings Call Transcript: Q1 2026


VolitionRx Earnings release: Q1 2026

May 15, 2026, 8:30 AM EDT - 3 months ago

VolitionRx Earnings release: Q1 2026


VolitionRx Quarterly report: Q1 2026

May 15, 2026, 8:30 AM EDT - 3 months ago

VolitionRx Quarterly report: Q1 2026


VolitionRx Slides: Corporate presentation

May 15, 2026, 7:00 AM EDT - 3 months ago

VolitionRx Slides: Corporate presentation


VolitionRx reports Q1 revenue $1M, consensus $409,920

2026-05-14T21:21:26.000Z - 3 months ago

VolitionRx reports Q1 revenue $1M, consensus $409,920


VolitionRx Proxy statement: Proxy filing

May 13, 2026, 8:00 AM EDT - 3 months ago

VolitionRx Proxy statement: Proxy filing


VolitionRx submits manuscript for Nu.Q Vet cancer test in cats

2026-05-07T06:07:48.000Z - 3 months ago

VolitionRx submits manuscript for Nu.Q Vet cancer test in cats


VolitionRx announces milestone in nucleosomes detection

2026-04-29T14:40:22.000Z - 4 months ago

VolitionRx announces milestone in nucleosomes detection


VolitionRx’s compliance plan accepted by NYSE American

2026-04-23T12:21:08.000Z - 4 months ago

VolitionRx’s compliance plan accepted by NYSE American


VolitionRx downgraded to Hold from Buy at D. Boral Capital

2026-04-20T12:05:06.000Z - 4 months ago

VolitionRx downgraded to Hold from Buy at D. Boral Capital


Volition Launches rNuQ™ Webshop Broadening Product Range

Apr 20, 2026, 7:30 AM EDT - 4 months ago

Volition Launches rNuQ™ Webshop Broadening Product Range


VolitionRx Earnings Call Transcript: Q4 2025

Apr 1, 2026, 8:30 AM EDT - 5 months ago

VolitionRx Earnings Call Transcript: Q4 2025


VolitionRx Annual report: Q4 2025

Apr 1, 2026, 8:30 AM EDT - 5 months ago

VolitionRx Annual report: Q4 2025


VolitionRx Earnings release: Q4 2025

Apr 1, 2026, 8:30 AM EDT - 5 months ago

VolitionRx Earnings release: Q4 2025


VolitionRx Slides: Corporate presentation

Apr 1, 2026, 7:00 AM EDT - 5 months ago

VolitionRx Slides: Corporate presentation


Why is VolitionRX Stock (VNRX) Up 24% Today?

2026-03-25T13:04:07.000Z - 5 months ago

Why is VolitionRX Stock (VNRX) Up 24% Today?


Volition Announces Detection of Over 95% of Early-Stage Cancers

Mar 25, 2026, 8:17 AM EDT - 5 months ago

Volition Announces Detection of Over 95% of Early-Stage Cancers


VolitionRx Proxy statement: Proxy Filing

Feb 11, 2026, 7:00 AM EST - 7 months ago

VolitionRx Proxy statement: Proxy Filing


VolitionRx receives non-compliance notice from NYSE American

2026-02-09T22:25:09.000Z - 7 months ago

VolitionRx receives non-compliance notice from NYSE American


VolitionRx Registration statement: Registration Filing

Feb 9, 2026, 7:00 AM EST - 7 months ago

VolitionRx Registration statement: Registration Filing


VolitionRx Proxy statement: Proxy Filing

Jan 26, 2026, 7:00 AM EST - 7 months ago

VolitionRx Proxy statement: Proxy Filing


Volition Continues to Extend Access to Nu.Q® Vet Cancer Test

Jan 20, 2026, 8:25 AM EST - 7 months ago

Volition Continues to Extend Access to Nu.Q® Vet Cancer Test


Volition Sponsors Symposium at Veterinary Meeting and Expo

Jan 16, 2026, 8:45 AM EST - 7 months ago

Volition Sponsors Symposium at Veterinary Meeting and Expo


VolitionRx Secures $2.0 Million in Funding

Jan 8, 2026, 9:15 AM EST - 8 months ago

VolitionRx Secures $2.0 Million in Funding


VolitionRx Slides: Corporate Presentation

Jan 8, 2026, 7:00 AM EST - 8 months ago

VolitionRx Slides: Corporate Presentation


Volition Issues Business Review 2025

Dec 17, 2025, 8:45 AM EST - 9 months ago

Volition Issues Business Review 2025


VolitionRx Earnings Call Transcript: Q3 2025

Nov 14, 2025, 8:30 AM EST - 10 months ago

VolitionRx Earnings Call Transcript: Q3 2025


VolitionRx Quarterly report: Q3 2025

Nov 14, 2025, 8:30 AM EST - 10 months ago

VolitionRx Quarterly report: Q3 2025


VolitionRx Earnings release: Q3 2025

Nov 14, 2025, 8:30 AM EST - 10 months ago

VolitionRx Earnings release: Q3 2025


VolitionRx Transcript: Status Update

Oct 8, 2025, 11:00 AM EDT - 11 months ago

VolitionRx Transcript: Status Update


Volition Sponsors Upcoming GenomeWeb Webinar

Oct 2, 2025, 8:45 AM EDT - 11 months ago

Volition Sponsors Upcoming GenomeWeb Webinar


Volition Signs Co-Marketing and Services Agreement with Hologic

Sep 29, 2025, 9:30 AM EDT - 11 months ago

Volition Signs Co-Marketing and Services Agreement with Hologic

HOLX


VolitionRx Slides: Corporate Presentation

Sep 11, 2025, 7:00 AM EDT - 1 year ago

VolitionRx Slides: Corporate Presentation


Volition Signs First Human Out Licensing Deal

Sep 9, 2025, 8:45 AM EDT - 1 year ago

Volition Signs First Human Out Licensing Deal


VolitionRx Slides: Corporate Presentation

Aug 29, 2025, 7:00 AM EDT - 1 year ago

VolitionRx Slides: Corporate Presentation


VolitionRx Earnings Call Transcript: Q2 2025

Aug 15, 2025, 8:30 AM EDT - 1 year ago

VolitionRx Earnings Call Transcript: Q2 2025


VolitionRx Quarterly report: Q2 2025

Aug 15, 2025, 8:30 AM EDT - 1 year ago

VolitionRx Quarterly report: Q2 2025


VolitionRx Earnings release: Q2 2025

Aug 15, 2025, 8:30 AM EDT - 1 year ago

VolitionRx Earnings release: Q2 2025


MoneyMacG
MoneyMacG Aug. 26 at 8:49 PM
0 · Reply
MoneyMacG
MoneyMacG Aug. 26 at 8:41 PM
0 · Reply
FormulaOneTrader
FormulaOneTrader Aug. 26 at 8:34 PM
0 · Reply
brwcy81
brwcy81 Aug. 26 at 6:38 PM
$VNRX An 8-K filed August 24 reported an additional 553,097 shares issued on August 20, 2026 to Lind Global Asset Management to satisfy a $250,000 convertible-note conversion. That brings the total to roughly 14.20 million.
0 · Reply
SerendipiTea
SerendipiTea Aug. 26 at 5:31 PM
$VNRX 29M shares traded. They must be dumping a massive amount of new shares on the market today via the ATM, timed to correlate with the sepsis PR knowing there would be a lot of liquidity from day traders.
1 · Reply
BinaryLogic
BinaryLogic Aug. 26 at 4:26 PM
$VNRX Debt conversion(s) to Lind in common stock, and then Lind liquidates those shares onto the market. The cycle will repeat until the liquidity issues that I have highlighted previously are resolved. Again-a licensing agreement with up front capital, milestone payments and ongoing double-digit royalties completely changes the valuation here (IMO) and should send the SP several hundred % higher from present levels. The key here is timing and execution, because the Lind dynamic will continue ongoing endlessly in the interim. $0.15-0.30 as I have consistently stated, and the SP is approaching that range now. A placement should have been done to this point - the endless ATM is equally damaging. https://www.sec.gov/Archives/edgar/data/93314/000147793226005251/0001477932-26-005251-index.html
1 · Reply
santihago
santihago Aug. 26 at 4:11 PM
$VNRX What a crime..
1 · Reply
Stanman13
Stanman13 Aug. 26 at 4:00 PM
$VNRX $12 a year ago... With time all things change.. 📈 great price to plant some seeds see if they sprout 🌱
0 · Reply
NGupup
NGupup Aug. 26 at 4:00 PM
$VNRX ☝️Now it's good ⬆️⬆️🔥
0 · Reply
brwcy81
brwcy81 Aug. 26 at 3:17 PM
$VNRX maybe bounce ah
0 · Reply
h00man89
h00man89 Aug. 26 at 3:13 PM
0 · Reply
AceofDubs
AceofDubs Aug. 26 at 2:51 PM
$VNRX Took my lumps, small position. Check out $SOAR, $CDTG, $LUCY
0 · Reply
SmartTrade99
SmartTrade99 Aug. 26 at 2:35 PM
$VNRX Catalyst: ⭐⭐⭐⭐⭐ Momentum potential: ⭐⭐⭐⭐⭐ Investment safety: ⭐⭐ Scalp potential: ⭐⭐⭐⭐⭐
0 · Reply
GABBYGIRL
GABBYGIRL Aug. 26 at 2:33 PM
$VNRX buy
0 · Reply
upupup16
upupup16 Aug. 26 at 2:08 PM
$VNRX shorts are so great at what they are doing
0 · Reply
Sharri3ff
Sharri3ff Aug. 26 at 2:07 PM
$VNRX damn that’s crazy! Premarket I forget can be fucking brutal if you’re not fast enough.
0 · Reply
DEAD_CATS_BOUNCE
DEAD_CATS_BOUNCE Aug. 26 at 2:04 PM
$VNRX Trying this out.
0 · Reply
SmartTrade99
SmartTrade99 Aug. 26 at 2:00 PM
$VNRX 15K added on this pullback, let's see if it flies again.
0 · Reply
Razied
Razied Aug. 26 at 1:59 PM
$VNRX bottom in lets fly 🔥
0 · Reply
DARKP00L
DARKP00L Aug. 26 at 1:59 PM
$VNRX 09:18 on Aug. 26 2026 Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis #tradeideas
0 · Reply
Bodi03
Bodi03 Aug. 26 at 1:47 PM
$VNRX new 52 week low. 🖕.
0 · Reply
Barryman1
Barryman1 Aug. 26 at 1:46 PM
$VNRX this was .66 premarket on good news Lol Why sell at this point
0 · Reply